Unlock your biotherapeutic development and manufacturing workflows with CHOSOURCE™ TnT transposon technology. Benefit from high clonal stability and consistent protein expression whilst reducing uncertainty and variability during cell line development. bit.ly/3mL6dEw

Join us for a FREE #LiveWebinar where Director of Cell-Based Screening, David Sorrell, will introduce Horizon's OncoSignature™ #LongTermAssay development and its ability to profile slower acting and epigenetic drugs. Register here: bit.ly/40hr9Ax #CellPanelScreening

In our new video series, learn how to elevate your experiments with #Dharmacon™ custom oligonucleotides. In the first episode, learn about synthesis ordering scale and what that means for your next RNA or DNA oligo design. bit.ly/3UOFIKU

Happy #EarthDay! We have continued our tradition of distributing seedlings for home gardens, cleaning up the nearby trail, and responsibly disposing of challenging-to-recycle materials like electronics and paint. Which green initiatives are you focusing on this year?

Horizon is #hiring for a variety of roles in the US and UK, including #LogisticsCoordinator, #ProductManager, #InsideSalesSpecialist, and more! Find all our open positions here: bit.ly/41rN35B

Cut time to market while ensuring your therapy is safe using our new iTreg polarization assay. Screen up to 13 compounds with data delivered in around 4 weeks! Find all the details in this week's #TechnicalTipTuesday: bit.ly/3UWMvlN

With the launch of our #OncoSignature™ Long-Term Assay, we conducted an interview with our expert, Dr. David Sorrell, to dive into the details of this service and its significance for your research. Read the white paper here: bit.ly/41F9l3n #CellPanelScreening

Our new video series shares tips on how to elevate your experiments with #Dharmacon™ custom oligonucleotides. In episode two, get a step-by-step guide to convert from nmols to micrograms and a quick demo of our internally developed conversion tool: bit.ly/41k7ilC

Drive efficiencies during biotherapeutic development and production with Horizon’s CHOSOURCE™ GS KO Expression Platform. These easy-to-use knockout cells have the ability to reach high expression levels giving you the results you need with less hassle. bit.ly/40oWv8v

Reveal the function of essential genes with our essential CRISPR reagent: inducible Cas9. In this week's #TechnicalTipTuesday, see how inducible Cas9 places control of gene editing in your hands: bit.ly/3nqITfG

Only 1 week until this FREE webinar introducing Horizon's OncoSignature™ Long-Term Assay! Join our Director of Cell-Based Screening as he dives into the assay’s development and its ability to profile slower acting and epigenetic drugs. Register here: bit.ly/40hr9Ax

Did you know that the iconic duo of C3PO and R2D2 from Star Wars have also inspired the names of proteins in the field of science? These proteins play a crucial role as "helpers" in the RNA pathway! #MayThe4thBeWithYou #StarWarsDay bit.ly/39C7Kpu

In this fascinating article from The Medicine Maker, explore the potential of fucosylation as a means of improving mAb efficacy and ultimately enhancing treatment outcomes. Read the full article here: bit.ly/3Vx5QKw

Get tips on how to elevate your experiments with #Dharmacon™ custom oligonucleotides with our new video series! Looking to modify your oligo, but unsure of where to start? In Ep. 3, we share considerations where to label or modify your custom oligo: bit.ly/42kzrt0

Are you attending #TIDESUSA this week? Make sure to visit with us at the day 1 reception and enjoy a signature cocktail, "The Dharmacon 2'ACE Swizzle". #Dharmacon #RNA TIDES - Informa Connect bit.ly/3LIXpHN

Horizon is seeking Senior Scientist 1 with a focus on Molecular Biology, and another in Cell Biology at our Cambridge, UK site! See the full job descriptions and apply today: bit.ly/3WRUfFG #hiring #BiotechJobs #CambridgeJobs

We appreciate your long-time interest and dedicated following. However, we'll soon be sharing our content on a new focused channel with a few of our closest friends. Keep an eye out as it will be happening very, very, soon.

Interested in #TCellExhaustion mechanisms? Wondering how #CRISPR screens can help? In our latest whitepaper, read an interview with Horizon’s Manager of Cell Based Screening, Verena Brucklacher-Waldert, as she details this exciting topic: bit.ly/3VG7ERH #Epigenetics

Don't forget to join us tomorrow for a FREE webinar where Director of Cell-Based Screening, Dr. David Sorrell, will introduce Horizon's OncoSignature™ Long-Term Assay development and its ability to profile slower acting and epigenetic drugs. Register: bit.ly/40hr9Ax

We have bittersweet news. Today, we chart a new course as Revvity. Stay apprised of our latest & greatest developments via a new, dedicated, life sciences handle, Revvity for Life Sciences. As such, this channel is now riding off into the sunset & will no longer be posting any content.